In addition, ALDH6A1 is significantly reduced in metastatic PCa compared with normal and primary PCa, an indication of that ALDH6A1 may be a predictive biomarker for metastatic PCa.223. This evidence concerns the gene ALDH6A1 and posterior cortical atrophy.